Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

The spinal implants market is estimated to grow by $3.55 billion from 2025 to 2029, according to research from Technavio.

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement, unanimously ...

On Jan. 28, Stryker Corp. announced plans to sell its U.S. spinal implant business to investment firm Viscogliosi Brothers. Though Stryker has a major share in the U.S. spine and orthopedic market, ...

A Florida federal judge has issued a report and recommended that a sales representative pay more than $19 million to resolve ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Globus specializes in developing and manufacturing orthopedic implants and regenerative products ... Founded in 2006, Nevro has developed the patented HFX spinal cord stimulation platform for ...